April 2011
Volume 52, Issue 14
ARVO Annual Meeting Abstract  |   April 2011
Corneal Cellular And Gene Therapy: Transduction Of Mesenchymal Stem Cells With An Ecdysone Inductible Lentiviral Vector Expressing Luciferase Gene
Author Affiliations & Notes
  • Anne Favard
    CHU Bretonneau, Tours, France
  • David Bellicaud
    CHU Bretonneau, Tours, France
  • Yannick Nochez
    CHU Bretonneau, Tours, France
  • Christine Collin
    CHU Bretonneau, Tours, France
  • Pierre Jean Pisella
    CHU Bretonneau, Tours, France
  • Eric E. Gabison
    Hopital Bichat AP-HP Cornea, Fondation A de Rothschild, Paris, France
  • Jean Christophe Pagès
    CHU Bretonneau, Tours, France
  • Footnotes
    Commercial Relationships  Anne Favard, None; David Bellicaud, None; Yannick Nochez, None; Christine Collin, None; Pierre Jean Pisella, None; Eric E. Gabison, None; Jean Christophe Pagès, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 5149. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Anne Favard, David Bellicaud, Yannick Nochez, Christine Collin, Pierre Jean Pisella, Eric E. Gabison, Jean Christophe Pagès; Corneal Cellular And Gene Therapy: Transduction Of Mesenchymal Stem Cells With An Ecdysone Inductible Lentiviral Vector Expressing Luciferase Gene. Invest. Ophthalmol. Vis. Sci. 2011;52(14):5149.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Several studies, using limbal stem cells or mesenchymal stem cells (MCSs), have confirmed the usefulness of these cells to repair epithelial and stromalcorneal tissue. However the reparation process might be hampered by a strong inflammatory reaction inducing non-physiologic remodelling of healing tissue. The use of genetically modified cells with inducible gene to control the stromal reaction might offer an opportunity to improve new treatments in ophthalmology.

Methods: : We aimed at transducing MSCs with an Ecdysone inducible lentivirus. To the end, we generated a conditional expression vector, expressing the luciferase under an ecdysone expression system. We have transduced MSCs and evaluated their ability to synthetize on « demand » the luciferase. Following validation of the process in cultured cells, the genetically modified cells will be evaluated in vivo, in rat.

Results: : Using an in vitro recombination system, we generated a lentiviral vector containing the luciferase as transgene, placed under an Ecdysone promoter (« E/Luc »). To obtain an effective control of the luciferase, we generated a second vector containing the RXR gene and VgEcR gene under a constitutive promoter (« V/R »). Viral recombinant vectors were produced through 293T cells. MSCs were first transduced by the « V/R » vectors followed by the "E/Luc" lentiviruses. At each step, we have tested the transduction by PCR. Finally, we have tested the responsiveness of the Ecdysone system in MSCs by adding Ponasterone and enzymatic activity of the Luc gene. Preliminary experiments using GFP-labeled MSC injected in normal rat corneal stroma allowed their detection ex-vivo after one month without any loss of transparency.

Conclusions: : The expression of the luciferase, using the above conditional expression vectors, has been validated in vitro. We predict that it could be applied to follow in vivo MSCs after their corneal engraftment. Upon validation of the system, the use of inducible gene expression could be applied to pathological wound-healing in a Sprague Dawley rat alkali burn injury model.

Keywords: cornea: basic science • gene transfer/gene therapy • wound healing 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.